0001415889-24-019022.txt : 20240702
0001415889-24-019022.hdr.sgml : 20240702
20240702180753
ACCESSION NUMBER: 0001415889-24-019022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240628
FILED AS OF DATE: 20240702
DATE AS OF CHANGE: 20240702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adler Reid G.
CENTRAL INDEX KEY: 0001924908
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37761
FILM NUMBER: 241097495
MAIL ADDRESS:
STREET 1: C/O VISTAGEN THERAPEUTICS, INC.
STREET 2: 343 ALLERTON AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94090
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vistagen Therapeutics, Inc.
CENTRAL INDEX KEY: 0001411685
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 205093315
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-577-3600
MAIL ADDRESS:
STREET 1: 343 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: VistaGen Therapeutics, Inc.
DATE OF NAME CHANGE: 20110610
FORMER COMPANY:
FORMER CONFORMED NAME: Excaliber Enterprises, Ltd.
DATE OF NAME CHANGE: 20070906
4
1
form4-07022024_100750.xml
X0508
4
2024-06-28
0001411685
Vistagen Therapeutics, Inc.
VTGN
0001924908
Adler Reid G.
C/O VISTAGEN THERAPEUTICS, INC.
343 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
CHF CORP DEVEL OFF, GEN COUNS
0
Common Stock
2024-06-28
4
A
0
4854
2.958
A
16509
D
Shares purchased under the Vistagen Therapeutics, Inc. 2019 Employee Stock Purchase Plan, as amended.
/s/ Cynthia Anderson, Attorney-in-Fact
2024-07-02